Loading clinical trials...
Loading clinical trials...
A Randomized Hybrid Type I Effectiveness-Implementation Study of an eHealth Delivery Alternative for Cancer Genetic Testing for Hereditary Cancer
Conditions
Interventions
Pre-Test Intervention
Standard of Care
+1 more
Locations
1
United States
Abramson Cancer Center at the University of Pennsylvania
Philadelphia, Pennsylvania, United States
Start Date
September 28, 2022
Primary Completion Date
December 24, 2025
Completion Date
July 1, 2026
Last Updated
January 16, 2026
NCT06696768
NCT06066138
NCT05198830
NCT04550494
NCT05245812
NCT03375307
Lead Sponsor
Abramson Cancer Center at Penn Medicine
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions